Geode Capital Management, LLC Aeglea Bio Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.35 - $1.54 $72,252 - $317,909	206,435 Added 52.39%	600,455 $270,000
Q2 2022 Aug 12, 2022	SELL	$0.5 - $2.66 $149,100 - $793,214	-298,201 Reduced 43.08%	394,020 $199,000
Q1 2022 May 13, 2022	BUY	$1.87 - $4.77 $12,110 - $30,890	6,476 Added 0.94%	692,221 $1.59 Million
Q4 2021 Feb 11, 2022	SELL	$3.5 - $8.42 $14,882 - $35,801	-4,252 Reduced 0.62%	685,745 $3.26 Million
Q3 2021 Nov 12, 2021	BUY	$6.03 - $7.95 $73,994 - $97,554	12,271 Added 1.81%	689,997 $5.49 Million
Q2 2021 Aug 13, 2021	BUY	$6.32 - $8.38 $125,489 - $166,393	19,856 Added 3.02%	677,726 $4.72 Million
Q1 2021 May 12, 2021	BUY	$6.76 - $8.57 $614,193 - $778,644	90,857 Added 16.02%	657,870 $5.21 Million
Q4 2020 Feb 12, 2021	SELL	$7.02 - $9.83 $10,143 - $14,204	-1,445 Reduced 0.25%	567,013 $4.46 Million
Q3 2020 Nov 13, 2020	SELL	$6.51 - $9.33 $92,350 - $132,355	-14,186 Reduced 2.43%	568,458 $4.03 Million
Q2 2020 Aug 13, 2020	BUY	$4.01 - $11.04 $1.06 Million - $2.91 Million	263,564 Added 82.6%	582,644 $5.39 Million
Q1 2020 May 14, 2020	BUY	$3.51 - $8.48 $20,740 - $50,108	5,909 Added 1.89%	319,080 $1.49 Million
Q4 2019 Feb 13, 2020	BUY	$7.23 - $8.55 $4,945 - $5,848	684 Added 0.22%	313,171 $2.39 Million
Q3 2019 Nov 12, 2019	BUY	$6.42 - $9.0 $86,066 - $120,654	13,406 Added 4.48%	312,487 $2.4 Million
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $355,904 - $512,269	58,345 Added 24.24%	299,081 $2.05 Million
Q1 2019 May 14, 2019	BUY	$7.6 - $9.4 $593,856 - $734,506	78,139 Added 48.06%	240,736 $1.94 Million
Q4 2018 Feb 13, 2019	BUY	$6.51 - $10.19 $54,098 - $84,678	8,310 Added 5.39%	162,597 $1.22 Million
Q3 2018 Nov 13, 2018	BUY	$8.24 - $11.0 $56,715 - $75,713	6,883 Added 4.67%	154,287 $1.48 Million
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $918,861 - $1.27 Million	116,755 Added 380.94%	147,404 $1.56 Million
Q2 2017 Aug 14, 2017	BUY	N/A	30,649	30,649 $117,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account